Lonza AG

Today Lonza is a global leader in life sciences. We are more than 15,000 employees in more than 100 locations around the world. Together in 2019, we achieved global sales of 5.9 CHF billion. We apply our industry knowledge to pioneer the medicines of tomorrow. Our work enables our customers to protect millions of people from illness and disease. The current COVID-19 situation clearly demonstrates how collaboration within our industry is the only way to beat pandemics, both now and in the future. We have recently been confirmed as the manufacturing partner for Moderna’s vaccine against the novel coronavirus, providing a tenfold manufacturing capacity increase. The vaccine (mRNA-1273) represents a significant opportunity to change the way we protect people against the pandemic. As other businesses face increasing economic uncertainty, we are fortunate to have opportunities for expansion at our sites in Switzerland and globally. To give you some options, if you want to experience the best of both worlds, Visp (CH) might be the right place for you. With a world-class science and technology facility you get more from your career, and we believe, more from life, too, with the amazing lifestyle that the Swiss Alps can offer. Drug Product Services in Stuecki, Basel (CH) focuses on parenteral dosage forms, including products for injection and infusion for intravenous, subcutaneous, intraocular and other routes of parenteral administration. Our services enable our clients to change patients’ lives! While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together, devising commitment and ideas that help our customers to help people. In exchange, we let our people own their careers. Their ideas, big and small, genuinely improve the world. And that’s the kind of work we want to be part of. Join us and make a Meaningful Difference!